Investigation of the frequency of polycystic ovary syndrome and its related factors in patients with severe acne
Keywords:
Ovary, Polycystic, Acne, WomenAbstract
Objective The objective of the study was conducted with the aim of determining the frequency of polycystic ovaries and their related factors in patients with severe acne. Â Methods This study was a cross-sectional study with a descriptive and analytical approach that was conducted using available sampling on 100 women with severe acne who referred to the skin clinic of Imam Khomeini Hospital in Jiroft in 2021. The data collection tool included a researcher-made checklist including history, and clinical examination, and based on that, patients with any specific symptom were referred for hormonal diagnostic tests such as free testosterone and total serum measurement. The data were analyzed with SPSS-18. Â Results The prevalence of PCOS with severe acne was 29% in patients in the south of Kerman province. There was a significant relationship between PCOS and severe acne in people with menstrual disorders (P<0.05), severe acne in people with and without exercise (P<0.05), BMI (P<0.05), and people with and without thyroid disorders (P<0.05). Â Conclusion A statistically significant relationship was found between the severity of acne and polycystic ovaries. Considering the effects of acne on women's hormonal screening, and ultrasound are recommended in girls with severe acne. ÂReferences
Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology- a systematic review. Hum Reprod Update. 2007;13(5):433-44.
Dokras A, Bochner M, Hollinrake E, Markham S, VanVoorhis B, Jagasia DH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol. 2005;106(1):131-7.
Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84(1):165-9.
Wild RA, Painter P, Coulson PB, CARRUTH KB, Ranney G. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1985;61(5):946-51.
Baillargeon J-P, Nestler JE. Polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab. 2006;91(1):22-4.
Wu XK, Zhou SY, Liu JX, Pöllänen P, Sallinen K, Mäkinen M, et al. Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. Fertil Steril. 2003;80(4):954-65.
Cattrall FR, Healy DL. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):803-12.
Hoeger KM. Obesity and lifestyle management in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2007;50(1):277-94.
Addor FASA, Schalka S. Acne in adult women: epidemiological, diagnostic and therapeutic aspects. Anais Brasileiros de Dermatologia. 2010;85:789-95.
Bunker C, Newton JA, Kilborn J, Patel A, Conway G, Jacobs H, et al. Most women with acne have polycystic ovaries. Br J Dermatol. 1989;121(6):675-80.
Borgia F, Cannavò S, Guarneri F, Cannavò SP, Vaccaro M, Guarneri B. Correlation between endocrinological parameters and acne severity in adult women. Acta Derm Vener Stockh. 2004;84(3):201-4.
Tahereh N, Marzieh A, Mohammad Hossein Dabagh M, Hamidreza T, Zahra Z. Frequency of facial and body acne in 14-to 18-year-old female high school students and its relationship to polycystic ovary syndrome. J Dermatol Cosmet. 2011;2(2):124-31.
Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, Ku SY, et al. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod. 2008;23(8):1924-31.
Diamantiâ€Kandarakis E, Panidis D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol. 2007;67(5):735-42.
Pehlivanov B, Orbetzova M. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol Endocrinol. 2007;23(10):604-9.
Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril. 2007;88(5):1389-95.
Belosi C, Selvaggi L, Apa R, Guido M, Romualdi D, Fulghesu A, et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Hum Rep. 2006;21(12):3108-15.
Hsu M-I, Liou T-H, Chou S-Y, Chang C-Y, Hsu C-S. Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990. Fertil Steril. 2007;88(3):727-9.
Farquhar CM, Birdsall M, Manning P, Mitchell JM, France JT. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust N Z J Obstet Gynaecol. 1994;34(1):67-72.
Conway G, Honour J, Jacobs H. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol. 1989;30(4):459-70.
Ghazanfarpour M, Dolatabadi Z, Bamorovat Z, Mahmoodabadi M, Salari Nasab J, Basari S, et al. Prevalence of Symptoms of Polycystic Ovary Syndrome and Some Associated Factors in Medical Students. J Babol Univ Med Sci. 2022;24(1):215-23.
Zar A, Karan KP, Ahmadi MA. Prevalence of obesity and overweight among female students of Shiraz University of Medical Sciences and its association with physical fitness factors. 2017.
Mohammadi M, Mahmoodi Darvishani S, Mirzaei M, Bahrololoomi Z, Sheikhi A, Bidbozorg H, et al. The prevalence of overweight and obesity among dental students Yazd University of Medical Sciences of Yazd in 2014. J Rafsanjan Univ Med Sci Health Serv. 2015;14(3):189-98.
Ehrmann DA. Polycystic ovary syndrome. New England Journal of Medicine. 2005;352(12):1223-36.
Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metabol. 2006;91(2):492-7.
Du D, Li X. The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis. Int J Clin Exp Med. 2013;6(10):880.
Puzigaić Z, Prelevic G, Stretenović Z, Balint-Perić L. Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome. Gynecol Endocrinol. 1991;5(3):167-74.
Bunker C, NEWTON JA, Conway G, Jacobs H, Greaves M, DOWD PM. The hormonal profile of women with acne and polycystic ovaries. Clin Exp Dermatol. 1991;16(6):420-3.
Vasheghani F, Jafari G. Polycystic ovarian disease in the females 15-45 years old referring to endocrine and gynaecology clinic of Imam khomeini hospital of Sari township. 2000-2001. J Mazandaran Uni Med Sci. 2002;12(36):52-9.
Van Hooff M, Voorhorst F, Kaptein M, Hirasing R, Koppenaal C, Schoemaker J. Endocrine features of polycystic ovary syndrome in a random population sample of 14–16 year old adolescents. Hum Reprod. 1999;14(9):2223-9.
Van Hooff M, Voorhorst F, Kaptein M, Hirasing R, Koppenaal C, Schoemaker J. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligoâ€amenorrhoea at age 18 years. Hum Reprod. 2004;19(2):383-92.
